An alternative route of the naloxone inhibitory effect on HNSCC cell proliferation was suggested by previous studies investigating the role of opioid growth factor (OGF), an endogenous native opioid that interacts with the OGF receptor (OGFr) to inhibit cell proliferation [33]. This evidence concerns the gene OGFR and head and neck squamous cell carcinoma.